Our data showed that the levels of B-ALL cells in both of rhTRAIL and MSC-sTRAIL treated mice were less than that in control PBS-treated mice, indicating that TRAIL could inhibit B-ALL cell proliferation in vivo. The gene discussed is TNFSF10; the disease is precursor B-cell acute lymphoblastic leukemia.